Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference20 articles.
1. Raffetto JD. Pathophysiology of chronic venous disease and venous ulcers. Surg Clin N Am. 2018;98(2):337–47. https://doi.org/10.1016/j.suc.2017.11.002.
2. das Graças C, de Souza M, Cyrino FZ, de Carvalho JJ, Blanc-Guillemaud V, Bouskela E. Protective effects of micronized purified flavonoid fraction (MPFF) on a novel experimental model of chronic venous hypertension. Eur J Vasc Endovasc Surg. 2018;55(5):694–702. https://doi.org/10.1016/j.ejvs.2018.02.009.
3. Cyrino FZ, Blanc-Guillemaud V, Bouskela E. Time course of microvalve pathophysiology in high pressure low flow model of venous insufficiency and the role of micronized purified flavonoid fraction. Int Angiol. 2021;40(5):388–94. https://doi.org/10.23736/S0392-9590.21.04726-X.
4. Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342–52. https://doi.org/10.1016/j.jvsv.2019.12.075.
5. Lugli M, Longhi M, Guerzoni S, Maleti O. Effect of micronized purified flavonoid fraction treatment on microscopic venous valves reflus in C0s and C1s patients with chronic venous disease [P24]. In: 21st virtual European venous forum meeting; 24–26 June 2021; virtual.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献